76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Qiagen NV
Closed
SectorHealthcare
48.53 1.04
Overview
Share price change
24h
Min
47.94
Max
48.88
Income | 2.4M 91M |
|---|---|
Sales | -38M 483M |
P/E Sector Avg | 110.535 39.564 |
EPS | 0.55 |
Dividend yield | 0.52 |
Profit margin | 18.773 |
Employees | 5,700 |
EBITDA | -12M 171M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +6.27% upside |
Dividend yield Sector Avg | 0.52% 2.40% |
|---|---|
Next Earnings | 5 Aug 2025 |
Market Cap | 1.2B 10B |
|---|---|
Previous open | 47.49 |
Previous close | 48.53 |
News Sentiment
By Acuity
22%
78%
40 / 376 Healthcare
Qiagen NV Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Qiagen NV Forecast
Price Target
By TipRanks
6.27% upside
12 Months Forecast
Average 50.85 USD 6.27%
High 56.258 USD
Low 43 USD
Based on 15 Wall Street analysts offering 12 month price targets forQiagen NV - Dist in the last 3 months.
Sentiment
By Acuity
40 / 376 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
